| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |